Lucid Diagnostics (LUCD)
NASDAQ:LUCD
US Market
Holding LUCD?
Track your performance easily

Lucid Diagnostics (LUCD) Financial Statements

330 Followers

Lucid Diagnostics Financial Overview

Lucid Diagnostics's market cap is currently ―. The company's EPS TTM is $-1.225; its P/E ratio is -0.75; Lucid Diagnostics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 446.00K$ 112.00K$ 76.00K$ 0.00$ 189.00K
Gross Profit$ -892.00K$ -62.00K$ -1.55M$ 0.00$ -180.00K
EBIT$ -16.21M$ -14.93M$ -14.35M$ -14.62M$ -12.10M
EBITDA$ -15.60M$ -14.31M$ -13.76M$ -13.92M$ -12.07M
Net Income Common Stockholders$ -16.25M$ -14.93M$ -14.35M$ -14.62M$ -12.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.52M$ 22.47M$ 26.93M$ 32.68M$ 47.92M
Total Assets$ 49.13M$ 32.51M$ 38.38M$ 45.40M$ 62.06M
Total Debt$ 13.78M$ 2.00M$ 2.00M$ 2.08M$ 2.22M
Net Debt$ -25.75M$ -20.48M$ -24.93M$ -30.60M$ -45.70M
Total Liabilities$ 24.22M$ 9.46M$ 10.84M$ 9.16M$ 15.57M
Stockholders Equity$ 24.91M$ 23.05M$ 27.53M$ 36.24M$ 46.49M
Cash Flow-
Free Cash Flow$ -7.06M$ -6.75M$ -6.67M$ -13.54M$ -5.92M
Operating Cash Flow$ -7.04M$ -4.26M$ -6.35M$ -13.30M$ -5.78M
Investing Cash Flow$ -17.00K$ -203.00K$ -1.32M$ -2.44M$ -148.00K
Financing Cash Flow$ 24.11M$ 1.00K$ 1.92M$ 501.00K$ 187.00K
Currency in USD

Lucid Diagnostics Earnings and Revenue History

Lucid Diagnostics Debt to Assets

Lucid Diagnostics Cash Flow

Lucid Diagnostics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis